Drug intelligence / Profile preview

Congxin Lunzhi Fang

Development stage
Preclinical
Lead developer
Guangzhou University of Chinese Medicine
Administration
Oral
01

Overview

Congxin Lunzhi Fang (CXLZF) is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for its therapeutic potential in treating atherosclerosis and related metabolic disorders. The formula is designed based on the "treating from the heart" (Congxin Lunzhi) theory of TCM. Preclinical studies in ApoE-/- mice have demonstrated that CXLZF significantly reduces atherosclerotic plaque size, enhances plaque stability by increasing collagen content, and lowers serum lipid levels. Additionally, it shows hepatoprotective effects by reducing serum transaminases (ALT and AST) and mitigating liver steatosis. The primary mechanism of action involves the upregulation of Angiotensin-Converting Enzyme 2 (ACE2) protein expression and the downregulation of the adhesion molecule E-selectin, thereby reducing vascular inflammation and protecting endothelial function.

Other names
Congxin Lunzhi FormulaCXLZF
02

Targets

ACE2 (Angiotensin-converting enzyme 2)

Beyond the preview

Go deeper on Congxin Lunzhi Fang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Congxin Lunzhi Fang.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call